Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Abitec Corporation
Abitec Corporation
Activities:
Ingredients
Drug Delivery
Pharmaceutical
Nutraceutical
X
LinkedIn
Trending Articles
Samsung Biologics signs $1.24bn biopharma manufacturing deal with Asian pharmaceutical giant
The CDMO will work with the client until the end of 2037, and will use its South Korean biomanufacturing site to serve them
Bespak and H&T Presspart announce availability of GMP pilot line for climate-friendly pMDIs
Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze
Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma
The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone
Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition
The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services
How AI and GenAI will revolutionise the healthcare industry
Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and...
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
ABITEC Corporation bolsters its high-purity lipid offerings for LNP therapeutics
The company can provide cGMP-grade lipids from a mg to a kg scale, assisting the production of advanced LNP therapeutics, including vaccines
Ingredients
DKSH signs exclusive distribution agreement with Abitec
The ingredients and specialty chemicals distributor has been selected to exclusively distribute a lipid excipient and nutritional supplement range in Thailand, Spain and Portugal
You need to be a subscriber to read this article.
Click here
to find out more.
Ingredients
Ingredients see a drive for more science
The need for greater solubility and bioavailability of new medicines, as well as increasing manufacturing efficiencies are driving developments in ingredients. Susan Birks reports on the latest trends
Subscribe now